{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T14:45:59Z","timestamp":1787928359889,"version":"build-2784847793"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1093\/jnen\/nlx043","type":"journal-article","created":{"date-parts":[[2017,6,19]],"date-time":"2017-06-19T15:12:10Z","timestamp":1497885130000},"page":"620-630","source":"Crossref","is-referenced-by-count":23,"title":["Bortezomib-Induced Muscle Toxicity in Multiple Myeloma"],"prefix":"10.1093","volume":"76","author":[{"given":"Valeria","family":"Guglielmi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominika","family":"Nowis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Tinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Malatesta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Paoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Marini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Manganotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radoslaw","family":"Sadowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz M.","family":"Wilczynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Meneghini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliano","family":"Tomelleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Vattemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,6,19]]},"reference":[{"key":"key\n\t\t\t\t20170619111209_nlx043-B1","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0140-6736(14)60493-1","article-title":"Multiple myeloma","volume":"385","year":"2015","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170619111209_nlx043-B2","first-page":"999","article-title":"Multiple myeloma: 2014 update on diagnosis, risk-stratification, and management","volume":"89","year":"2014","journal-title":"Am J Hematol"},{"key":"key\n\t\t\t\t20170619111209_nlx043-B3","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1182\/blood-2007-10-116129","article-title":"Improved survival in multiple myeloma and the impact of novel therapies","volume":"111","year":"2008","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170619111209_nlx043-B4","first-page":"S24","article-title":"Management of treatment-related adverse events in patients with multiple myeloma","volume":"36(Suppl. 2)","year":"2010","journal-title":"Cancer Treat Rev"},{"key":"key\n\t\t\t\t20170619111209_nlx043-B5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1471-2407-6-129","article-title":"Severe reversible cardiac failure after bortezomib treatment combined with chemotherapy in a non-small cell lung cancer patient: a case report","volume":"6","year":"2006","journal-title":"BMC Cancer"},{"key":"key\n\t\t\t\t20170619111209_nlx043-B6","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1365-2141.2007.06659.x","article-title":"Unexpected cardiotoxicity in haematological bortezomib treated patients","volume":"138","year":"2007","journal-title":"Br J Haematol"},{"key":"key\n\t\t\t\t20170619111209_nlx043-B7","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s12185-008-0139-7","article-title":"Acute severe cardiac failure in a myeloma patient due to proteasome inhibitor bortezomib","volume":"88","year":"2008","journal-title":"Int J Hematol"},{"key":"key\n\t\t\t\t20170619111209_nlx043-B8","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1212\/WNL.25.1.58","article-title":"A new program for investigating adult human skeletal muscle grown aneurally in tissue culture","volume":"25","year":"1975","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170619111209_nlx043-B9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/978-1-62703-317-6_6","article-title":"Human myoblasts from skeletal muscle biopsies: in vitro culture preparations for morphological and cytochemical analyses at light and electron microscopy","volume":"976","year":"2013","journal-title":"Methods Mol Biol"},{"key":"key\n\t\t\t\t20170619111209_nlx043-B10","first-page":"2515","article-title":"Low ozone concentrations stimulate cytoskeletal organization, mitochondrial activity and nuclear transcription","volume":"59","year":"2015","journal-title":"Eur J Histochem"},{"key":"key\n\t\t\t\t20170619111209_nlx043-B11","article-title":"SERCA1 protein expression in muscle of patients with Brody disease and Brody syndrome and in cultured human muscle fibers","volume":"20","year":"2013","journal-title":"Mol Genet Metab"},{"key":"key\n\t\t\t\t20170619111209_nlx043-B12","first-page":"273","article-title":"Review. Clinical pharmacokinetics of bortezomib","volume":"21","year":"2007","journal-title":"In Vivo"},{"key":"key\n\t\t\t\t20170619111209_nlx043-B13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00280-010-1283-3","article-title":"Pharmacokinetic and pharmacodynamic study of two doses of bortezomib in patients with relapsed multiple myeloma","volume":"67","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"key":"key\n\t\t\t\t20170619111209_nlx043-B14","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.expneurol.2006.11.010","article-title":"Bortezomib-induced peripheral neurotoxicity: a neurophysiological and pathological study in the rat","volume":"204","year":"2007","journal-title":"Exp Neurol"},{"key":"key\n\t\t\t\t20170619111209_nlx043-B15","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1002\/glia.21065","article-title":"Pathological adaptive responses of Schwann cells to endoplasmic reticulum stress in bortezomib-induced peripheral neuropathy","volume":"58","year":"2010","journal-title":"Glia"},{"key":"key\n\t\t\t\t20170619111209_nlx043-B16","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.2353\/ajpath.2010.090690","article-title":"Cardiotoxicity of the anticancer therapeutic agent bortezomib","volume":"176","year":"2010","journal-title":"Am J Pathol"},{"key":"key\n\t\t\t\t20170619111209_nlx043-B17","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S1470-2045(10)70206-0","article-title":"Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65\/GMMG-HD4 trial","volume":"11","year":"2010","journal-title":"Lancet Oncol"},{"key":"key\n\t\t\t\t20170619111209_nlx043-B18","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.metabol.2009.07.009","article-title":"Skeletal muscle insulin resistance: the interplay of local lipid excess and mitochondrial dysfunction","volume":"59","year":"2010","journal-title":"Metabolism"},{"key":"key\n\t\t\t\t20170619111209_nlx043-B19","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.1182\/blood-2005-08-3531","article-title":"Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells","volume":"107","year":"2006","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170619111209_nlx043-B20","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1182\/blood-2008-04-149385","article-title":"Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature","volume":"112","year":"2008","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170619111209_nlx043-B21","doi-asserted-by":"crossref","first-page":"12358","DOI":"10.18632\/oncotarget.2590","article-title":"Bortezomib induces AMPK-dependent autophagosome formation uncoupled from apoptosis in drug resistant cells","volume":"5","year":"2014","journal-title":"Oncotarget"},{"key":"key\n\t\t\t\t20170619111209_nlx043-B22","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00280-014-2451-7","article-title":"Bortezomib induces protective autophagy through AMP-activated protein kinase activation in cultured pancreatic and colorectal cancer cells","volume":"74","year":"2014","journal-title":"Cancer Chemother Pharmacol"},{"key":"key\n\t\t\t\t20170619111209_nlx043-B23","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1177\/0300060513490618","article-title":"Bortezomib induces apoptosis and autophagy in osteosarcoma cells through mitogen-activated protein kinase pathway in vitro","volume":"41","year":"2013","journal-title":"J Int Med Res"},{"key":"key\n\t\t\t\t20170619111209_nlx043-B24","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.cellsig.2012.10.004","article-title":"Bortezomib\/proteasome inhibitor triggers both apoptosis and autophagy-dependent pathways in melanoma cells","volume":"25","year":"2013","journal-title":"Cell Signal"},{"key":"key\n\t\t\t\t20170619111209_nlx043-B25","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/cdd.2011.27","article-title":"Proteasome inhibition can induce an autophagy-dependent apical activation of caspase-8","volume":"18","year":"2011","journal-title":"Cell Death Differ"},{"key":"key\n\t\t\t\t20170619111209_nlx043-B26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4161\/auto.6.1.10323","article-title":"Bortezomib blocks the catabolic process of autophagy via a cathepsin-dependent mechanism, affects endoplasmic reticulum stress and induces caspase-dependent cell death in antiestrogen-sensitive and resistant ER+ breast cancer cells","volume":"6","year":"2010","journal-title":"Autophagy"},{"key":"key\n\t\t\t\t20170619111209_nlx043-B27","doi-asserted-by":"crossref","first-page":"e1510","DOI":"10.1038\/cddis.2014.468","article-title":"Bortezomib enhances cancer cell death by blocking the autophagic flux through stimulating ERK phosphorylation","volume":"5","year":"2014","journal-title":"Cell Death Dis"}],"container-title":["Journal of Neuropathology & Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnen\/article-pdf\/76\/7\/620\/17744944\/nlx043.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T19:54:58Z","timestamp":1503604498000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnen\/article-lookup\/doi\/10.1093\/jnen\/nlx043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,19]]},"references-count":27,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,6,19]]},"published-print":{"date-parts":[[2017,7]]}},"URL":"https:\/\/doi.org\/10.1093\/jnen\/nlx043","relation":{},"ISSN":["0022-3069","1554-6578"],"issn-type":[{"value":"0022-3069","type":"print"},{"value":"1554-6578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,19]]}}}